BTMD biote Corp.

Nasdaq biote.com


$ 2.72 $ -0.13 (-4.58 %)    

Friday, 07-Nov-2025 15:59:56 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.71
$ 2.82
$ 2.65 x 1,000
$ 2.84 x 14,645
$ 2.71 - $ 2.82
$ 2.65 - $ 6.98
78,473
na
123.75M
$ 0.41
$ 4.30
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-14-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-15-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-29-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-21-2022 03-31-2022 10-Q
16 04-07-2022 12-31-2021 10-K
17 11-24-2021 09-30-2021 10-Q
18 08-17-2021 06-30-2021 10-Q
19 05-20-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biote-affirms-fy2025-sales-guidance-of-190000m-vs-192670m-est

Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $190.000 million to $190.000 million vs $192.670 million estimate.

 biote-q3-eps-022-beats-007-estimate-sales-47956m-beat-47757m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29...

 b-riley-securities-downgrades-biote-to-neutral-lowers-price-target-to-4

B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target...

 biote-lowers-fy2025-sales-guidance-from-202000m-208000m-to-190000m-vs-204667m-est

Biote (NASDAQ:BTMD) lowers FY2025 sales outlook from $202.000 million-$208.000 million to $190.000 million vs $204.667 million ...

 biote-q2-eps-010-beats-006-estimate-sales-4890m-miss-4952m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 58.73 ...

 biote-affirms-fy2025-sales-guidance-of-20200m-20800m-vs-20531m-est

Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $202.00 million-$208.00 million to $202.00 million-$208.00 million vs $20...

 biote-q1-eps-037-beats-007-estimate-sales-4899m-beat-4699m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.07 by 428.57...

 biote-sees-fy25-revenue-202m-208m-vs-22718m-est-adj-ebitda-59m-64m

The Company expects the following for fiscal 2025:($ in millions)2025 Guidance Ranges  Revenue$202-$208Adjusted EBITDA2$59-6420...

 biote-q4-2024-gaap-eps-010-inline-sales-49834m-miss-51245m-estimate

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 44.44 pe...

 craig-hallum-maintains-buy-on-biote-lowers-price-target-to-8

Craig-Hallum analyst Alex Fuhrman maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $12 to $8.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION